Evidence map›Paper›PMID 42379824›Full record

ArticleMicrobiology spectrum2026

Emergence and persistence of ESBL- and carbapenemase-producing

Victoria Ballén, Karol Delgado, Anna Pinar-Méndez, Carles Vilaró, Belén Galofré, Sara Martí, Aida González-Díaz, Manuel Alcalde-Rico, Sara M Soto

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Victoria BallénISGlobal, Barcelona, Spain.ORCID 0000-0003-1089-600X
Karol DelgadoISGlobal, Barcelona, Spain.
Anna Pinar-MéndezAigües de Barcelona, Empresa Metropolitana de Gestió del Cicle Integral de l'Aigua, Barcelona, Spain.
Carles VilaróAigües de Barcelona, Empresa Metropolitana de Gestió del Cicle Integral de l'Aigua, Barcelona, Spain.
Belén GalofréAigües de Barcelona, Empresa Metropolitana de Gestió del Cicle Integral de l'Aigua, Barcelona, Spain.ORCID 0009-0009-4208-8884
Sara MartíMicrobiology Department, Hospital Universitari Bellvitge, IDIBELL-UB, L'Hospitalet de Llobregat, Spain.ORCID 0000-0002-0405-2305
Aida González-DíazMicrobiology Department, Hospital Universitari Bellvitge, IDIBELL-UB, L'Hospitalet de Llobregat, Spain.ORCID 0000-0002-8326-1307
Manuel Alcalde-RicoCSIC, Universidad de Sevilla, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen Macarena, Seville, Spain.
Sara M SotoISGlobal, Barcelona, Spain.ORCID 0000-0002-9507-105X

Funding

Instituto de Salud Carlos III PI19/00478SOCIEDAD GENERAL DE AGUAS DE BARCELONA, S.A.U. N1
6 · The paper itself

Abstract

The World Health Organization classifies extended-spectrum beta-lactamase (ESBL) and carbapenemase-producing

Indexed as

Bacterial Proteinsbeta-LactamasesKlebsiella pneumoniaeWastewaterAnti-Bacterial AgentsDrug Resistance, Multiple, BacterialHumansKlebsiella InfectionsMicrobial Sensitivity TestsSpainVirulence FactorsWater PurificationAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseVirulence FactorsWastewaterantimicrobial resistanceheavy metal tolerance genesKlebsiella pneumoniaeOne Healthvirulencewastewater treatment plants

Identifiers

PMID42379824
PMCPMC13436359

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.